Insider · CIK 0002120002
Matthew S. Forsyth
Files at TMDX (TransMedics Group, Inc.). First filing -, latest -.
In brief
Matthew S. Forsyth files SEC Form 4 as officer at TMDX (TransMedics Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew S. Forsyth has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +15,409 | $0.00 | $0 | 15,409 | May 21, 2026 |
| May 19, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +23,171 | $0.00 | $0 | 23,171 | May 21, 2026 |
Questions about Matthew S. Forsyth
Answered from the filings on this page, as of the latest one.
Is Matthew S. Forsyth buying or selling?
Matthew S. Forsyth has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew S. Forsyth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew S. Forsyth has 0.
Where does Matthew S. Forsyth file Form 4?
Matthew S. Forsyth has filed Form 4 at TMDX (TransMedics Group, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.